Dreeming big.
Dreem Announces $35 Million Financing from lead investors Johnson & Johnson Innovation and Bpifrance (press release):
“Dreem, a neurotechnology company, today announced the closing of a new round of funding, raising $35 million USD to rapidly accelerate product development, invest in strategic research and development, and advance the future of sleep technology. Last year, Dreem introduced a comprehensive solution to address a suite of sleep problems and enhance the quality of rest during the night. The Dreem headband monitors brain activity to track sleep accurately and uses auditory stimulation as a medium to help people fall asleep faster, get deeper sleep, and wake up refreshed.
With the $35 million investment, led by strategic investor JJDC, Dreem will bring next-generation sleep technology to markets across the globe and continue to invest in R & D for future sleep-related scientific discoveries and technological innovations … Dreem previously raised a total of $22 million, from billionaire French entrepreneur Xavier Niel, entrepreneur and biotech investor Dr. Laurent Alexandre, and one of the top French insurance leaders — MAIF. With additional investment from JJDC and Bpifrance, Dreem has raised nearly $60 million in less than four years.”
Comments are closed.